Bioequivalence Study: 3 mg Estradiol Valerate (EV) With and Without Levomefolate Calcium
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Investigation of the bioequivalence (BE) of Estradiol Valerate (EV) after administration of
one film-coated tablet containing 3 mg Estradiol Valerate and 0.451 mg Levomefolate calcium
as compared to one film-coated tablet containing 3 mg Estradiol Valerate Investigation of the
bioequivalence of levomefolate calcium after administration of one film-coated tablet
containing 3 mg Estradiol Valerate and 0.451 mg Levomefolate calcium as compared to one
film-coated tablet containing 0.451 mg levomefolate calcium